2004, Packaging and Pharmacokinetics

AI in Drug Discovery - A Highly Opinionated Literature Review (Part II)

Practical Cheminformatics

JANUARY 8, 2024

A 2004 paper by Vigers and Rizzi proposed a similar strategy for docking studies. In addition to optimizing potency against a target of interest, we must design selective compounds with optimal pharmacokinetic profiles and a host of other desirable properties. It should be noted that this isn’t a new idea. What’s old is new again.

Drugs

Drugs Small Molecule Bioinformatics Packaging

Making a “Miracle” HIV Medicine

Codon

FEBRUARY 23, 2025

million by 2004. Pharmaceutical developers often avoid fluorine because the element can alter pharmacokinetics, making it hard to predict how a drug will be absorbed, metabolized, and excreted. By Kamal Nahas Scientists had no antiretroviral drugs when the AIDS crisis began in 1981. For more than two decades, the U.S.

Clinical Trials

Clinical Trials Virus Vaccine DNA

Drug Discovery Digest

AI in Drug Discovery - A Highly Opinionated Literature Review (Part II)

Making a “Miracle” HIV Medicine

Webinars

Stay Connected